Genalyte Receives National Cancer Institute Grant

Brad Webb

Our portfolio company Genalyte just announced the award of a government grant from the National Cancer Institute for the development of a diagnostic system using Genalyte’s proprietary biomarker technology (see Genalyte Expands into Cancer Profiling with $1 Million NCI Grant to Develop Cancer Biomarker Panel). This project is a significant validation of the company’s capability to assay blood biomarkers using the multiplex Maverick detection platform, which provides rapid, accurate, . . .
→ Read full post: Genalyte Receives National Cancer Institute Grant

Numedii co-founder Atul Butte featured in Science article on “Dry Biology” research

Ted Driscoll

Atul J. Butte, M.D., Ph.D.

Big Data Guru and Stanford Medical School Professor Atul Butte, co-founder of Numedii had his work recently profiled in the journal SCIENCE. As the article claims, the explosion of publicly available databases housing sequences, structures, and images allows life scientists to make fundamental discoveries without ever getting their hands “wet” at the lab bench. Science . . .
→ Read full post: Numedii co-founder Atul Butte featured in Science article on “Dry Biology” research

Alphabet Energy and Clean Power Finance honored at Global Cleantech 100 Gala

Paul Straub

The Global Cleantech 100 Gala honored and celebrated the achievements of the 2013 Global Cleantech 100 companies, the 100 top innovators in cleantech today.

Two of Claremont Creek Ventures portfolio companies, Alphabet Energy and Clean Power Finance were named to the list to the top 100 Global Cleantech companies. . . .
→ Read full post: Alphabet Energy and Clean Power Finance honored at Global Cleantech 100 Gala